Assignee
CORCEPT THERAPEUTICS INC
US·119 granted patents·64 pending applications·1,150 citations·filing 2000–2025
Top patents by PatentIndex Score
183 records- 0199US10898478B2Glucocorticoid receptor modulators to treat cervical cancerCORCEPT THERAPEUTICS INC·Filed 2020·Granted Jan 26, 2021·15 cites·20 claims
- 0298US11058670B2Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorCORCEPT THERAPEUTICS INC·Filed 2020·Granted Jul 13, 2021·13 cites·22 claims
- 0398US10568880B2Glucocorticoid receptor modulators to treat cervical cancerCORCEPT THERAPEUTICS INC·Filed 2018·Granted Feb 25, 2020·22 cites·14 claims
- 0498US10456392B2Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Oct 29, 2019·25 cites·26 claims
- 0598US10413540B2Glucocorticoid receptor modulators to treat cervical cancerCORCEPT THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·25 cites·10 claims
- 0698US10323034B2Octahydro fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Jun 18, 2019·20 cites·14 claims
- 0798US10047082B2Octahydro fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2014·Granted Aug 14, 2018·40 cites·18 claims
- 0898US9956216B2Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2017·Granted May 1, 2018·40 cites·20 claims
- 0998US9943505B2Glucocorticoid receptor modulators to treat pancreatic cancerCORCEPT THERAPEUTICS INC·Filed 2017·Granted Apr 17, 2018·47 cites·18 claims
- 1098US9829495B2Method for differentially diagnosing ACTH-dependent Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2016·Granted Nov 28, 2017·26 cites·18 claims
- 1198US9707223B2Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2016·Granted Jul 18, 2017·44 cites·19 claims
- 1298US9273047B2Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2014·Granted Mar 1, 2016·66 cites·18 claims
- 1398US8859774B2Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2013·Granted Oct 14, 2014·67 cites·23 claims
- 1497US11684612B2Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorCORCEPT THERAPEUTICS INC·Filed 2022·Granted Jun 27, 2023·8 cites·20 claims
- 1597US11660295B2Glucocorticoid receptor modulators to treat cervical cancerCORCEPT THERAPEUTICS INC·Filed 2020·Granted May 30, 2023·5 cites·18 claims
- 1697US11590113B2Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorCORCEPT THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·8 cites·22 claims
- 1797US11576907B2Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2021·Granted Feb 14, 2023·6 cites·10 claims
- 1897US11560379B2Octahydro fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2021·Granted Jan 24, 2023·6 cites·3 claims
- 1997US11370789B2Octahydro fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2020·Granted Jun 28, 2022·8 cites·15 claims
- 2097US10973813B2Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Apr 13, 2021·16 cites·27 claims
- 2197US10828280B2Glucocorticoid receptor modulators to treat pancreatic cancerCORCEPT THERAPEUTICS INC·Filed 2020·Granted Nov 10, 2020·9 cites·21 claims
- 2297US10646474B2Glucocorticoid receptor modulators to treat pancreatic cancerCORCEPT THERAPEUTICS INC·Filed 2019·Granted May 12, 2020·12 cites·21 claims
- 2397US10213414B2Glucocorticoid receptor modulators to treat pancreatic cancerCORCEPT THERAPEUTICS INC·Filed 2018·Granted Feb 26, 2019·38 cites·21 claims
- 2497US10117852B2Glucocorticoid receptor modulators to treat pancreatic cancerCORCEPT THERAPEUTICS INC·Filed 2018·Granted Nov 6, 2018·35 cites·21 claims
- 2596US11744837B2Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patientsCORCEPT THERAPEUTICS INC·Filed 2020·Granted Sep 5, 2023·4 cites·7 claims
- 2696US11648245B2Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2021·Granted May 16, 2023·4 cites·25 claims
- 2796US10787449B2Octahydro fused azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Sep 29, 2020·11 cites·16 claims
- 2896US7928237B2Fused ring azadecalin glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2005·Granted Apr 19, 2011·87 cites·10 claims
- 2995US11890289B2Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2021·Granted Feb 6, 2024·4 cites·9 claims
- 3095US11793810B2Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2021·Granted Oct 24, 2023·2 cites·18 claims
- 3195US11548856B2Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2021·Granted Jan 10, 2023·6 cites·9 claims
- 3295US11202784B2Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiencyCORCEPT THERAPEUTICS INC·Filed 2020·Granted Dec 21, 2021·5 cites·11 claims
- 3395US10881660B2Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Jan 5, 2021·9 cites·23 claims
- 3495US9943526B2Optimizing mifepristone levels for cushing's patientsCORCEPT THERAPEUTICS INC·Filed 2016·Granted Apr 17, 2018·12 cites·9 claims
- 3594US12285425B2Glucocorticoid receptor modulators to treat cervical cancerCORCEPT THERAPEUTICS INC·Filed 2023·Granted Apr 29, 2025·1 cites·13 claims
- 3694US11760731B2Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2022·Granted Sep 19, 2023·4 cites·17 claims
- 3794US10980797B2Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitorsCORCEPT THERAPEUTICS INC·Filed 2017·Granted Apr 20, 2021·6 cites·13 claims
- 3894US10449178B2Glucocorticoid receptor modulators to treat pancreatic cancerCORCEPT THERAPEUTICS INC·Filed 2019·Granted Oct 22, 2019·10 cites·21 claims
- 3994US10151763B2Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2017·Granted Dec 11, 2018·6 cites·30 claims
- 4094US7678813B2Azadecalin Glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2005·Granted Mar 16, 2010·42 cites·21 claims
- 4193US11285145B2Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4CORCEPT THERAPEUTICS INC·Filed 2021·Granted Mar 29, 2022·5 cites·30 claims
- 4293US7576076B2Modified pyrimidine glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2005·Granted Aug 18, 2009·48 cites·12 claims
- 4392US11925626B2Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compoundCORCEPT THERAPEUTICS INC·Filed 2022·Granted Mar 12, 2024·5 cites·21 claims
- 4492US11464764B2Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compoundCORCEPT THERAPEUTICS INC·Filed 2019·Granted Oct 11, 2022·11 cites·23 claims
- 4592US11327083B2Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndromeCORCEPT THERAPEUTICS INC·Filed 2018·Granted May 10, 2022·4 cites·29 claims
- 4692US10314850B1Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patientsCORCEPT THERAPEUTICS INC·Filed 2019·Granted Jun 11, 2019·4 cites·30 claims
- 4792US10238659B2Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2015·Granted Mar 26, 2019·13 cites·14 claims
- 4891US11944617B2Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4CORCEPT THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·2 cites·16 claims
- 4991US11787780B2Quaternary indazole glucocorticoid receptor antagonistsCORCEPT THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·3 cites·28 claims
- 5091US11213526B2Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulatorsCORCEPT THERAPEUTICS INC·Filed 2018·Granted Jan 4, 2022·3 cites·34 claims
Showing the top 50 of 183 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CORCEPT THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →